What to expect from the Wesfarmers (ASX:WES) first half result

Here's what to expect from the Wesfarmers Ltd (ASX:WES) half year results next month…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

With earnings season on the horizon, I have been looking at what is expected from some of Australia's most popular companies.

On this occasion, I'm going to take a look at conglomerate Wesfarmers Ltd (ASX: WES).

What is expected from Wesfarmers in the first half of FY 2021?

According to a note out of Goldman Sachs, it is expecting a strong half year result from Wesfarmers next month.

Goldman is forecasting underlying revenue of $17,616.2 million for the six months ended 31 December. This is up 15.5% on the prior corresponding period. It is also 2.6% higher than the consensus estimate of $17,171 million.

This is expected to be driven by growth across almost the entirety of the business. Though, the biggest driver will be the key Bunnings business, which Goldman is expecting to deliver a 22.3% increase in revenue to $8,899.4 million.

This is expected to be supported by an 8.4% jump in Department Stores revenue to $5,406.7 million and a 25.6% increase in Officeworks revenue to $1,546.1 million.

And thanks to margin expansion of 120 basis points, offset slightly by a lower property earnings contribution, Goldman estimates that the company will report a 12.5% increase in earnings before interest and tax (EBIT) to $1,831.8 million.

Finally, underlying net profit after tax is forecast to grow 12.7% to $1,269.8 million, allowing the Wesfarmers board to declare an interim dividend of 84.1 cents per share. This will be up 12.2% on last year's interim dividend.

Though, it is worth noting that in respect to its dividend, Goldman does see upside risk. It commented: "However, we note that there is risk to the upside through a special dividend given the strong balance sheet position and the guidance for c. 85% of payout ratio (which we forecast on a full year basis)."

Is the Wesfarmers share price in the buy zone?

At present, Goldman feels Wesfarmers' shares are fully valued and has reaffirmed its neutral rating and lifted its price target to $48.30.

This compares to the latest Wesfarmers share price of $55.27.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of Wesfarmers Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

man with dog on his lap looking at his phone in his home.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

Two workers at an oil rig discuss operations.
Broker Notes

Should you buy Santos, Beach Energy or Woodside shares? Here's Macquarie's top pick

Macquarie has released its new share price expectations for Santos, Beach Energy and Woodside shares.

Read more »

A green fully charged battery symbol surrounded by green charge lights representing the surging Vulcan share price today
Share Market News

Up 300% in 6 months! This soaring ASX lithium stock just took a major step to production

Marching forward.

Read more »

An old-fashioned panel of judges each holding a card with the number 10
Share Gainers

Here are the top 10 ASX 200 shares today

It was a happy end to the trading week this Friday.

Read more »

Broker written in white with a man drawing a yellow underline.
Broker Notes

Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A young man pointing up looking amazed, indicating a surging share price movement for an ASX company
Share Market News

Macquarie says this top ASX tech stock could rise 15%

Let's see what the broker is saying about this stock.

Read more »

Excited couple celebrating success while looking at smartphone.
Healthcare Shares

Up 680% since July, here's why 2025 was a breakout year for this hot ASX stock

With consistent contract wins, FDA clearance, and backing from Pro Medicus, 4D Medical is showing that there is a commercial…

Read more »

A male investor wearing a blue shirt looks off to the side with a miffed look on his face as the share price declines.
Share Fallers

Why Collins Foods, Monash IVF, Premier Investments, and Step One shares are tumbling today

These shares are ending the week in the red. But why?

Read more »